Wet Age-Related Macular Degeneration (AMD) Market by Product (Lucentis, Eylea, Avastin), by Distribution Channel (Direct, Indirect), by Age Group (Above 80 Years, 60–80 Years, 40–59 Years), by Route of Administration (Intravitreal, Intravenous), by End User (Hospitals & Clinics, Research & Academic Institutes), by Geography (U.S., Canada, Germany, France, U.K., Italy, Spain, Russia, Sweden, Norway, Belgium, Switzerland, Austria, China, Japan, India, South Korea, Malaysia, Thailand, Australia, Singapore, Brazil, Mexico, Argentina, Colombia, Israel, South Africa, Saudi Arabia) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2014–2024

Wet Age-Related Macular Degeneration (AMD) Market (2014–2024)
Published Report Code Available Format Pages
 March 2019  LS11640    175

Place an order

USD 4900
USD 5900
USD 7500
We use cookies to enhance your experience. By continuing to use this site you consent to our use of cookies. More info X